Loading provider…
Loading provider…
Hematology & Oncology Physician in Cincinnati, OH
NPI: 1295728459Primary Practice Location
THE JEWISH HOSPITAL-MERCY HEALTH
4777 E Galbraith Rd, Cincinnati, OH
Primary Employer
Cincinnato PET Scan
ohcare.com
HQ Phone
Get MD Edward's Phone Numberphone_androidMobile
Get MD Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
IN State Medical License
OH State Medical License
OH State Medical License
1996 - 2027
IN State Medical License
1984 - 2025
KY State Medical License
1996 - 2025
MO State Medical License
1994 - 2019

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Indiana University School Of Medicine
medicine.iu.edu
Fellowship • Hematology and Medical Oncology
1988 - 1989
Residency • Internal Medicine
1982 - 1986
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Fellowship • Hematology and Medical Oncology
1986 - 1988
Saint Louis University School Of Medicine
slu.edu
Medical School
Until 1982
Saint Louis University
B.A. • Summa Cum Laude
Until 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 16 | 38 |
Excessive Zinc Ingestion: A Reversible Cause of Sideroblastic Anemia and Bone Marrow Depression
Authors: Guido Tricot
Journal: JAMA
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Imatinib, DRUG: Bosutinib, DRUG: Nilotinib, DRUG: Dasatinib, DRUG: Asciminib
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: ABL001
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Decitabine, DRUG: Cytarabine, OTHER: Observation, DRUG: Clofarabine, PROCEDURE: Allogeneic hematopoietic stem cell transplantation, DRUG: Daunorubicin